Halozyme Therapeutics reported $1.03B in Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acadia Pharmaceuticals ACAD:US $ 724.43M 30.74M
Agios Pharmaceuticals AGIO:US $ 1874.6M 613.83M
Alnylam Pharmaceuticals ALNY:US $ 3509.43M 254.16M
Amarin AMRN:US $ 1044.99M 54.74M
Amgen AMGN:US $ 59773M 2766M
Aptinyx Inc APTX:US $ 134.17M 18.72M
Arena Pharmaceuticals ARNA:US $ 1084.66M 99.28M
Baxter International BAX:US $ 19682M 216M
Cara Therapeutics CARA:US $ 221.45M 28.77M
Cytokinetics CYTK:US $ 564.3M 12.76M
Eli Lilly And LLY:US $ 47809M 970.7M
Esperion Therapeutics ESPR:US $ 280.46M 1.86M
Halozyme Therapeutics HALO:US $ 1025.86M 59.28M
Immunogen IMGN:US $ 301.45M 44.52M
Intercept Pharmaceuticals ICPT:US $ 523.22M 3.11M
Intra Cellular Therapies ITCI:US $ 625.7M 48.79M
Intrexon XON:US $ 402.57M 4.41M
JAZZ PHA JAZZ:US $ 13212.99M 6456.52M
Mannkind MNKD:US $ 252.79M 66.59M
Minerva Neurosciences NERV:US $ 105.32M 6.51M
Nektar Therapeutics NKTR:US $ 1371.35M 85.21M
Peregrine Pharmaceuticals PPHM:US $ 270.53M 5.02M
Rigel Pharmaceuticals RIGL:US $ 201.6M 14.4M
United Therapeutics UTHR:US $ 4844.9M 203.9M
Vanda Pharmaceuticals VNDA:US $ 567.64M 24.45M